×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
3 weeks ago
22
The EU support of Imfinzi for early-stage gastric and gastroesophageal cancers expands the statement of 1 of the company’s top-selling oncology medicines.
Read Entire Article
Homepage
Technology
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
Related
How to Switch AI Chatbots—and Why You Might Want To
12 hours ago
3
Record-breaking Artemis II mission ends with 'perfect splash...
22 hours ago
3
China’s state media turns to social media and AI to tell its...
1 day ago
5
Popular
Canada's Artemis II astronaut gives thumbs-up to 'Project Ha...
6 days ago
16
Simple Bread Pudding, Spring Vegetables Every Which Way and ...
6 days ago
14
Stephen Miller Is Still Pursuing His Immigration Agenda, but...
6 days ago
13
The Historic Turnaround That Took Michigan From Disaster to ...
6 days ago
13
The Myth of the Lone Inventor Is Largely Just That—a Myth
6 days ago
13